30
Views
4
CrossRef citations to date
0
Altmetric
Case Report

A case with life-threatening interstitial pneumonia associated with bucillamine treatment

, , , , &
Pages 522-525 | Received 10 Mar 2008, Accepted 17 Apr 2008, Published online: 02 Jan 2014

References

  • Sekiguchi N, Kameda H, Amano K, Takeuchi T. Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with rheumatoid arthritis. Mod Rheumatol. 2006;16:85–91.
  • Hara A, Sakamoto 0, Matsumoto M, et al. A case of bucillamine-induced interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30:1743-8 (in Japanese).
  • Tanaka H, Nakahara K, Goto K. A case of bucillamine-induced pneumonitis. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30: 695–701 (in Japanese).
  • Inokuma S, Sakata M, Yoshida A, Shiratori K, Kiyosawa H. Bucillamine induced pulmonary injury occurs with immuno-globulin decrease. J Rheumatol. 1996;23:1282–5.
  • Fukino K, Shiota T, Nakaya Y, et al. A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamone. Bronchology. 1997;19:232-6 (in Japanese).
  • Lee YH, Kim YR, Ji JD, et al. A case of BOOP developed during bucillamine treatment for rheumatoid. Korean J Intern Med. 2001;16:36–9.
  • Matsushima H, Takayanagi N, Sakamoto T, et al. A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine. Nihon Kokyuki Gakkai Zasshi. 2001;39(1):55–9 (in Japanese).
  • Miwa Y, Kaga S, Hanaoka R, et al. A case of rheumatoid arthritis complicated with a pneumonitis during concomitant treatment with methotrexate and bucillamine. Ryumachi. 2002;42:70-5 (in Japanese).
  • Kishimoto N, Fujii K. A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi. 2002;40: 321–5 (in Japanese).
  • Tanimura K, Shimizu M, Matsuhashi M, Shinohara M, Sagawa A. A case of interstitial pneumonia caused by bucillamine: a study using serological markers. Mod Rheumatol. 2006;16:39–43.
  • Nanke Y, Yamada T, Kamatani N. Asymptomatic interstitial pneumonitis induced by bucillamine in a patient with rheumatoid arthritis. Mod Rheumatol. 2005;15:381–2.
  • Kajiya T, Kuroda A, Hokonohara D, Tei C. Radiographic appearance of bronchiolitis obliterans organizing pneumonia (BOOP) developing during Bucillamine treatment for rheumatoid arthritis. Am J Med Sci. 2006;332:39–42.
  • Saito Y, Nei T, Abe S, et al. A case of bucillamine-induced interstitial pneumonia with positive lymphocyte stimulation test for bucillamine using bronchoalveolar lavage lymphocytes. Intern Med. 2007;46:1739–43.
  • Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
  • Brown KK. Rheumatoid lung disease. Proc Am Thorac Soc. 2007;4:443–8.
  • Negishi M, Kaga S, Kasama T, et al. Lung injury associated with bucillamine therapy. Ryumachi. 1992;32:135-9 (in Japanese).
  • Kurashima K, Nakao S, Fujimura M, Matsuda T. Bucillamine-induced hypersensitivity pneumonitis. Chest. 1992;101:1479–80.
  • Battaglia S, Sandrini MC, Catalano F, et al. Effects of aging on sensation of dyspnea and health-related quality of life in elderly asthmatics. Aging Clin Exp Res. 2005;17:287–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.